First Time Loading...

Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 304 JPY -0.86% Market Closed
Updated: May 8, 2024

Kobayashi Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kobayashi Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4911
4527
4927
4452
F
4921

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Operating Income
¥25.8B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
4%
Shiseido Co Ltd
TSE:4911
Operating Income
¥19.3B
CAGR 3-Years
9%
CAGR 5-Years
-29%
CAGR 10-Years
-9%
Rohto Pharmaceutical Co Ltd
TSE:4527
Operating Income
¥40.6B
CAGR 3-Years
25%
CAGR 5-Years
14%
CAGR 10-Years
9%
Pola Orbis Holdings Inc
TSE:4927
Operating Income
¥16.1B
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
0%
Kao Corp
TSE:4452
Operating Income
¥86.6B
CAGR 3-Years
-21%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
F
Fancl Corp
TSE:4921
Operating Income
¥11.5B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
14%

See Also

What is Kobayashi Pharmaceutical Co Ltd's Operating Income?
Operating Income
25.8B JPY

Based on the financial report for Dec 31, 2023, Kobayashi Pharmaceutical Co Ltd's Operating Income amounts to 25.8B JPY.

What is Kobayashi Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was -3%.